TGFB1 and pulmonary fibrosis: The inhibition of EndoMT has been found to ameliorate pulmonary fibrosis in both lipopolysaccharide-induced lung injury and transforming growth factor-beta (TGF-β)-induced pulmonary fibrosis [14,15].